TCROSS News
journal Conference Topics Feature

List of Conference Articles

Long-term DAPT Beyond 12 Months After DES Implantation in Patients With Multivessel Coronary Artery Disease: The DAPT-MDV Trial
AHA 2025|
Long-term DAPT Beyond 12 Months After DES Implantation in Patients With Multivessel Coronary Artery Disease: The DAPT-MDV Trial
Ticagrelor vs Prasugrel After PCI in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Trial
AHA 2025|
Ticagrelor vs Prasugrel After PCI in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Trial
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Trial
AHA 2025|
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Trial
Short Dual Antithrombotic Therapy After PCI In Patients With Atrial Fibrillation: The OPTIMA-AF Trial
AHA 2025|
Short Dual Antithrombotic Therapy After PCI In Patients With Atrial Fibrillation: The OPTIMA-AF Trial
The Annual AHA Scientific Sessions 2025 was held in New Orleans
AHA 2025|
The Annual AHA Scientific Sessions 2025 was held in New Orleans
Selution SLR Sirolimus-Eluting Balloon for Femoropopliteal Artery Lesions in Patients With and Without Diabetes: 3-Year Results From the SELUTION SFA Japan Trial
VIVA 2025|
Selution SLR Sirolimus-Eluting Balloon for Femoropopliteal Artery Lesions in Patients With and Without Diabetes: 3-Year Results From the SELUTION SFA Japan Trial
VIVA 25 - What Were This Year’s Late-Breaking Clinical Trials? -
VIVA 2025|
VIVA 25 - What Were This Year’s Late-Breaking Clinical Trials? -
Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: The NATURE Trial
TCT 2025|
Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: The NATURE Trial
Long-Term Clinical Outcomes After Bioadaptor vs Onyx Stent Implantation in Patients With Ischemic Heart Disease: 2-Year Follow-Up of the INFINITY-SWEDEHEART Trial
TCT 2025|
Long-Term Clinical Outcomes After Bioadaptor vs Onyx Stent Implantation in Patients With Ischemic Heart Disease: 2-Year Follow-Up of the INFINITY-SWEDEHEART Trial
PCI of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior CABG: The PROCTOR Trial
TCT 2025|
PCI of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior CABG: The PROCTOR Trial
Paclitaxel-Coated Balloon Plus Bailout Stenting vs Planned DES Implantation for De Novo Coronary Lesions: 3-Year Outcomes of the REC-CAGEFREE I Trial
TCT 2025|
Paclitaxel-Coated Balloon Plus Bailout Stenting vs Planned DES Implantation for De Novo Coronary Lesions: 3-Year Outcomes of the REC-CAGEFREE I Trial
Comparison of Drug-Coated Versus Conventional Balloons for Treatment of Side Branches of Bifurcation Lesions: The OCVC-BIF Study
TCT 2025|
Comparison of Drug-Coated Versus Conventional Balloons for Treatment of Side Branches of Bifurcation Lesions: The OCVC-BIF Study
Intravascular Lithotripsy vs Cutting Balloon for Calcified Coronary Lesions: The ShortCUT Trial
TCT 2025|
Intravascular Lithotripsy vs Cutting Balloon for Calcified Coronary Lesions: The ShortCUT Trial
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial
ESC 2025|
Digital Twin-Guided Patient Specific Rotor Ablation for Persistent Atrial Fibrillation: The CUVIA Trial
Inclisiran-based Strategy Versus Individually Optimized Lipid-lowering Therapy: The VICTORION-Difference Study
ESC 2025|
Inclisiran-based Strategy Versus Individually Optimized Lipid-lowering Therapy: The VICTORION-Difference Study
Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Trial
ESC 2025|
Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Trial
Timing of Complete Revascularization During Index Hospitalisation in Patients With STEMI and Multivessel Disease: The OPTION-STEMI Trial
ESC 2025|
Timing of Complete Revascularization During Index Hospitalisation in Patients With STEMI and Multivessel Disease: The OPTION-STEMI Trial
3-Month vs 12-Month DAPT After ACS: The DUAL-ACS Trial
ESC 2025|
3-Month vs 12-Month DAPT After ACS: The DUAL-ACS Trial
Early Aspirin Discontinuation Following PCI in Low-Risk Acute MI Patients: The TARGET FIRST Trial
ESC 2025|
Early Aspirin Discontinuation Following PCI in Low-Risk Acute MI Patients: The TARGET FIRST Trial
Early Aspirin Discontinuation vs DAPT After PCI in Patients With ACS: The NEO-MINDSET Trial
ESC 2025|
Early Aspirin Discontinuation vs DAPT After PCI in Patients With ACS: The NEO-MINDSET Trial
Assessment of Quitting versus Using Aspirin Therapy In Patients with Stabilized Coronary Artery Disease after Stenting who Require Long-term Oral Anticoagulation: The AQUATIC Trial
ESC 2025|
Assessment of Quitting versus Using Aspirin Therapy In Patients with Stabilized Coronary Artery Disease after Stenting who Require Long-term Oral Anticoagulation: The AQUATIC Trial
Effect of Drug-Coated Devices in Patients with CLTI and Intermittent Claudication: The SWEDEPAD Trial
ESC 2025|
Effect of Drug-Coated Devices in Patients with CLTI and Intermittent Claudication: The SWEDEPAD Trial
ESC Congress 2025 Closes with 33,000 Participants and 484 Presentations from Japan
ESC 2025|
ESC Congress 2025 Closes with 33,000 Participants and 484 Presentations from Japan
High-Risk Plaques Observed by CT and Future Cardiac Events in Patients with FFR-Negative Chronic Coronary Syndrome: The CAPTURE Trial
CVIT 2025|
High-Risk Plaques Observed by CT and Future Cardiac Events in Patients with FFR-Negative Chronic Coronary Syndrome: The CAPTURE Trial
Intravascular Lithotripsy for Coronary Lesions in Real-World Practice: Reports from International Registries and a Japanese Single-Center Experience
CVIT 2025|
Intravascular Lithotripsy for Coronary Lesions in Real-World Practice: Reports from International Registries and a Japanese Single-Center Experience
Current Status of PCI for ACS in Japan: Insights From the J-PCI Registry and a CVIT Survey
CVIT 2025|
Current Status of PCI for ACS in Japan: Insights From the J-PCI Registry and a CVIT Survey
The impact of a Perfusion Balloon for ACS compared with Direct Stent and Conventional Therapy
CVIT 2025|
The impact of a Perfusion Balloon for ACS compared with Direct Stent and Conventional Therapy
Impact of Delayed Referral on Clinical Outcomes in Patients with CLTI: The COMET Study
CVIT 2025|
Impact of Delayed Referral on Clinical Outcomes in Patients with CLTI: The COMET Study
Clinical Outcomes and Predictors of Endovascular Treatment for Aortoiliac Artery In-Stent Restenosis: A Multicenter Retrospective Study
CVIT 2025|
Clinical Outcomes and Predictors of Endovascular Treatment for Aortoiliac Artery In-Stent Restenosis: A Multicenter Retrospective Study
DES vs DCB for Treatment Femoropopliteal Arteries: 3-Year Outcomes from the BEASTARS Registry
CVIT 2025|
DES vs DCB for Treatment Femoropopliteal Arteries: 3-Year Outcomes from the BEASTARS Registry